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Abstract
Background: Sebaceous cell carcinoma of the eyelid is a malignant tumor. However, the pathoetiology of
sebaceous cell carcinoma is not clear. Retinoic acid (RA) signaling is essential for skin epidermal differentiation
including the eyelids. In this study, we investigate the expression of β-catenin, RA-binding proteins and RA
receptors in sebaceous cell carcinoma of the eyelid and try to estimate their influence on its pathoetiology.
Methods: Retrospective, noncomparative, consecutive interventional case series. Sixteen cases of eyelid sebaceous gland
carcinoma who received tumor excision at our hospital between 2001 and 2011 were included. Immunohistochemical
staining for β-catenin, cellular retinoic acid binding protein 1 (CRABP1), cellular retinoic acid binding protein 2 (CRABP2),
fatty acid-binding protein 5 (FABP5), retinoic acid receptors (RAR-α, −β, −γ), and retinoid X receptors (RXR-α, −β, −γ) was
performed on tissue samples obtained from tumor excision.
Results: Of the 16 sebaceous cell carcinoma cases reviewed, six were male and 10 female. The mean follow-up
period was 6.7 ± 3.66 years (range, 0.3–13 years). Of these 16 cases, the expression of β-catenin was significantly
increased in sebaceous cell carcinoma cases. CRABP1 was similarly expressed in the sebaceous cell carcinoma
and control groups. CRABP2 and FABP5 were expressed in hair follicles of lid skin in both groups, whereas the
CRABP2 and FABP5 were aberrantly expressed in the tumor cells of the sebaceous glands. Notably, the expression of
retinoic acid receptor (RAR-β) and retinoid X receptors (RXR-β, −γ) was significantly upregulated in sebaceous cell
carcinoma of the eyelids.
Conclusions: Our findings indicate that retinoic acid signaling is related to the pathogenesis of sebaceous cell
carcinoma of the eyelids.
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Background
Sebaceous cell carcinoma (SeCC) of the eyelid is a highly
aggressive malignant tumor that arises from the meibomian
glands, Zeiss glands of the eyelid, or sebaceous glands of
the caruncle [1]. Sebaceous cell carcinoma is more frequent
in Asians than in Caucasians. In the West it accounts for
only 0.2–4.7 % of all eyelid malignancies [2] whereas in Asia
it accounts for 11–33 %. The prevalence of SeCC is 8–23 %
in Taiwan. Sebaceous cell carcinoma is notorious for mas-
querading as other benign and malignant lesions, often
resulting in delayed diagnosis. In addition, diffuse epithelial
involvement (pagetoid growth pattern) is present in about
half of the cases. Therefore, it is usually associated with a
high risk of recurrence and metastatic diseases. Other fac-
tors associated with a poor prognosis include vascular,
lymphatic or orbital invasion, involvement of both upper
and lower eyelids, poor differentiation, multi-centric origin,
highly infiltrative pattern, and tumor size more than 2 cm.
Etiological risk factors of SeCC include radiation exposure,
advanced age, and a genetic predisposition to Muir–Torre
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syndrome, which includes sebaceous adenoma and seba-
ceous carcinoma [2–5].
Unfortunately, the prognosis of SeCC is unpredictable.
To date, there are no specific reliable markers available for
predicting the prognosis of the patients. The retinoids have
been reported to affect the growth and differentiation of
epithelial tissue and to play an important role in essential
biologic processes, differentiation, proliferation, and apop-
tosis [6–10]. Furthermore, retinoids, whose biological func-
tions are mainly mediated by retinoid receptors, have been
used as a therapy for some non-melanoma skin cancers
[11]. The cellular retinoic acid-binding proteins (CRABPs)
may regulate the accessibility of retinoic acid (RA) to the
RA receptors and are thought to affect the prognosis of
cancer. In particular, CRABP1 is expressed in hair follicles
of normal skin (dermal papilla) and in the stroma of epider-
mal tumors. A member of the fatty acid-binding protein
(FABP) family, FABP5, is found abundantly in skin epider-
mal cells, adipocytes, macrophages, liver, heart, sebaceous
glands, and anagen follicle bulbs [11, 12]. Previous experi-
ments indicate that CRABP2 and FABP5 are abundantly
expressed in the differentiating cells of sebaceous glands,
interfollicular epidermis, and hair follicles [11]. Therefore,
combinations of RA receptors and CRABPs may be an im-
portant factor in mediating the effects of RA on transcrip-
tion and cellular processes. Moreover, the dynamic patterns
of expression of CRABPs also reflect cross talk of RA and
Wnt/β-catenin signaling in different developmental and
homeostatic situations [11, 13–17]. Aberrant expression of
β-catenin has been reported in different tumors such as
colorectal, hepatocellular, breast carcinoma, oral squamous
cell carcinoma, and non-melanoma skin tumors [18]. The
RA receptors are nuclear receptors related to the steroid
and thyroid hormone receptors. So far, two classes of nu-
clear retinoid receptors (RARs and RXRs) have been
reported, and each has three main subtypes, −α, −β, and -γ.
They play a pivotal role as ligand-dependent transcription
factors. RA receptors act in heterodimeric combinations
with retinoid X receptors (RXRs) and facilitate DNA
binding of the RAR–RXR complex [19]. RA signaling
is mediated by RA binding to RARs, which form het-
erodimers with RXRs, and is regulated by RA-binding
proteins [19, 20]. Retinoids, that are Vitamin A deriva-
tives, as ligands for binding to these nuclear receptor
transcription factors (RARs and RXRs), are strongly as-
sociated with the development of skin cancer and its
subsequent prognosis.
Therefore, we aimed to investigate the role of RA sig-
naling pathway in the pathogenesis of SeCC. In this
study, we retrospectively analyzed the variation in the
immunohistochemical expression of related signaling
pathway binding proteins between SeCC cases and nor-
mal control cases, and tried to explore the role of RA
pathway in the pathogenesis of SeCC.
Methods
Ethics statement, subject recruitment, and clinical
assessment
No animal experiments were conducted in this study. This
retrospective study to examine human eyelid tissues with
sebaceous cell carcinoma was approved by the Institu-
tional Review Board of Chang Gung Memorial Hospital,
Linko, Taiwan (registry numbers 100-3459B). All proce-
dures conformed to the Declaration of Helsinki and the
ARVO statement for research involving human subjects.
Written consent was obtained before use of the patients’
tissues for histological study. Nineteen eyelids, 16 from pa-
tients with sebaceous cell carcinoma of eyelids and three
from patients with conjunctival nevus, were included in
this study. Sebaceous cell carcinoma was classified accord-
ing to the 7th edition eyelid carcinoma classification sys-
tem from the American Joint Committee on Cancer. The
clinical history and follow-up duration for each evaluated
case was recorded.
Patient demographics and clinical features
From 2001 to 2011, six male patients and 10 female pa-
tients, with a female preponderance (M: F ratio of 0.6),
were included in the SeCC group in this study. The
mean age was 66.4 ± 2.28 years (range, 46–77 years),
and the median follow-up duration was 6.7 ± 3.66 years
(range, 0.3–13 years). One male patient and two female
patients were included in the control group. The mean
age was 78.7 ± 0.33 years (range, 78–79 years). The gen-
eral information and clinical data of patients with seba-
ceous cell carcinoma were listed in Table 1. Clinical
images of sebaceous cell carcinoma of eyelids (SeCC)
were presented at Fig. 1.
Conventional surgery remained the main treatment
modality for sebaceous cell carcinoma. To minimize
the risk of recurrence, complete excision with allowing
a wide tumor-free margin 3–5 mm was essential for
SeCC cases. At the time of primary excision, or for sub-
sequent excision of residual tumor, the margins were
checked with frozen section technique. Planned surgi-
cal reconstruction of the defect was then undertaken.
Complete resection and primary closure could be ac-
complished for the defects less than 10 mm. Tenzel ro-
tational flap was often necessary to mobilize enough
skin to facilitate wound closure for the defects around
half of the length of eyelid. Larger defects might need
lid-sharing procedure from the opposite lid. Conjunc-
tival and tarsal replacement using tarsal flaps or graft-
ing with oral mucosa or hard palate graft, combined
with topical chemotherapy stood as a conservative
treatment in cases that were not far advanced. Exenter-
ation was justified for advanced diffuse disease with an-
terior orbital soft tissue invasion.
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Table 1 General information and clinical data of patients with sebaceous cell carcinoma
No. Primary surgery Primary staging Subaequent follow-up F/U Mortality
Staging TNM Local recur LN meta Distant meta Staging Mx
1 Hughs IC T2bN0M0 N Y N III B Surgery + R/T 8.5 Ys N
2 Tenzel IB T2aN0M0 U U U 0.3 Ys U
3 Tenzel IC T2bN0M0 N N N Observation 1.3 Ys N
4 Tenzel IB T2aN0M0 Y N N II Local excision 8.5 Ys Y
5 Tenzel IB T2aN0M0 Y N N IC Local excision 6 Ys Y
6 Tenzel IB T2aN0M0 N N N Observation 8 Ys N
7 Tenzel IB T2aN0M0 Y Y Y IV Exenteration 8 Ys Y
8 Tenzel IB T2aN0M0 N N N Observation 13 Ys N
9 Tenzel IB T2aN0M0 Y N N II Local excision 11 Ys N
10 Hughs II T3aN0M0 Y Y Y IV C/T 1.5 Ys Y
11 Tenzel IB T2aN0M0 Y N N III A Exenteration 9.5 Ys N
12 Cutler-beard IC T2bN0M0 Y Y N III B C/T 8 Ys Y
13 Cutler-beard IC T2bN0M0 N N N Observation 8 Ys N
14 Cutler-beard IC T2bN0M0 Y N N II Local excision 4 Ys N
15 Tenzel IB T2aN0M0 N N N Observation 8.5 Ys N
16 Tarsus replaced III A T3bN0M0 Y Y Y IV R/T+ C/T 3 Ys Y
No.: Patient number; C/T: chemoterapy; R/T: radiation therapy
Fig. 1 External eye photos and hematoxylin-eosin staining of sebaceous cell carcinoma (SeCC) of eyelids. a-d: Preoperative photos show (a) A fleshy
mass arising from the lower eyelid tarsus (Case 2), (b) A small ulcerated nodule at the right upper eyelid (Case 6), (c) An ill-defined lesion involving the
upper eyelid, masquerading as blepharitis (Case 12), (d) An advanced tumor diffusely infiltrative growth that involves the whole upper tarsus (Case 16).
e-h: The corresponding scanning views (4×) of hematoxylin-eosin sections of the eyelid-conjunctiva specimens labled as A-D in the upper row. i-l:
Higher power magnification of scanning views in the middle row shows (i) solid sheets of pleomorphic carcinoma cells without apparent sebaceous
differentiation (×20), (j) irregular and interconnecting nests of carcinoma cells with foamy cytoplasmic droplets indicative of sebaceous differentiation
(×40), (k) intraepithelial (pagetoid) growth of sebaceous carcinoma cells involving the epidermis (×20), (l) a comedo pattern of sebaceous carcinoma
showing central necrosis (×20)
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Immunohistochemistry
Immunohistochemical analysis was performed to deter-
mine the expression of the proteins of interest in tissue
sections. All samples had been fixed with 4 % paraformal-
dehyde in phosphate buffered saline soon after tumor exci-
sion and embedded in paraffin. Then samples were cut
into 4 μm thick sections and mounted on glass slides. After
deparaffinization, rehydration, and blocking with 5 % goat
serum for 1 h, the sample slides were incubated at 4 °C
overnight with the following primary antibodies (Table 2),
including antibodies against β-catenin, cellular retinoic
acid-binding proteins (CRABP1, CRABP2), fatty acid-
binding protein 5 (FABP5), retinoic acid receptors -α, −β,
and -γ (RAR-α, −β, −γ), and retinoid X receptors -α, −β,
and -γ (RXR-α, −β, −γ). The slides incubated with irrele-
vant immunoglobulin (IgG) were used as negative controls.
All the primary antibodies used in this study were known
to be specific to target proteins, and no obvious cross-
reactions with any other proteins were noted. After wash-
ing, the sections were incubated at room temperature for
1 h with appropriate secondary antibodies, including goat
anti-rabbit IgG-B (β-catenin, CRABP2, FABP5, RAR-β,
RAR-γ), goat anti-mouse IgG-B (CRABP1), and donkey
anti-goat IgG-B (RAR-α). Non-specific reactions were
blocked by incubating sample slides with 2.5 % bovine
serum albumin (BSA) in PBS for 30 min. At the end,
the samples were observed by microscope and photo-
graphed. Tissue sections were also processed for routine




At initial presentation, there were nine patients staging
as T2a, five patients staging as T2b, one patient staging
as T3a, and one patient staging as T3b. None of our
SeCC patients received primary exenteration; five pa-
tients underwent wide surgical excision with the
opposite lid sharing procedure, 10 patients underwent
wide excision and local reconstruction with Tenzel rota-
tional flap, and one received total replacement of tarsus
due to diffuse tarsal involvement (Case 16). Local tumor
recurrence was noted in nine patients during the follow-
up period. No lymph node metastasis was detected in
our SeCC patient group at the time of diagnosis, and
subsequent lymph node metastasis was found in five
cases; distant metastasis was found in three patients dur-
ing the follow-up period. There were no significant dif-
ferences regarding patient’s demographic features,
including age and sex, or follow-up periods between the
group with metastasis and the group without metastasis
(Table 1). Fig. 1 presents the clinical and pathological
images of the SeCC cases. Pre-operative clinical photo-
graph showed a fleshy mass arising from the lower eyelid
margin of a 68-year-old male (Case 2, Fig. 1a). Fig. 1b
presented a nodule of sebaceous carcinoma at the right
upper eyelid of a 54-year-old female (Case 6). No local re-
currence had been noted after 8-year follow-up. Figure 1c
presented an ill-demarcated lesion diffusely involving the
left upper eyelid of a 74-year-old female, masquerading as
blepharitis (Case 12). Fig. 1d showed an advanced seba-
ceous carcinoma case involving the whole right upper tar-
sus of a 71-year-old male, who died 3 years after due to
systemic metastasis (Case 16). Tissue sections for routine
H & E staining were shown in Fig. 1e-l.
Immunohistochemistry
β-Catenin, a transcription factor of the Wnt signaling
pathway, is a component of the adherens junction. It sup-
ports Ca2+-dependent cell-to-cell contact for adhesion,
and plays a role in both signal transmission and anchoring
the actin cytoskeleton. Most specimens presented a mem-
branous accumulation of β-catenin with some elevated
cytoplasmic levels in 81 % of the SeCC cases (n = 13/16,
81 %) (Fig. 2). The aberrant membranous-cytoplasmic ex-
pression of β-catenin was found in SeCC cases (Fig. 2a–h)
compared with control case (Fig. 2i). No nuclear staining
of β-catenin was observed in any of the SeCC cases.
Therefore, the membranous-cytoplasmic overexpression
of β-catenin in some cases of SeCC may be caused in part
by dysregulation of theWnt/β-catenin pathway.
Figures 3 and 4 showed the CRABP1 and CRABP2 pro-
teins were expressed in tumor cells of the SeCC cases, re-
spectively. Figure 3a-e presented that the CRABP1 protein
was expressed in tumor cells of the SeCC cases (n = 12/16,
75 %) with mild to moderate intensity (Fig. 3a-e). Fig. 4a-g
showed that the aberrant expression of the CRABP2 pro-
tein was found in the tumor cells of SeCC cases (n = 15/16,
93.75 %) with moderate to strong intensity, whereas the
CRABP2 protein was only mild-to-moderate weak expres-
sion in the control cases (Fig. 4h, i).
Table 2 Primary antibodies, concentration and sources
Antibody Category Dilution Source
β-catenin Rabbit polyclonal 1: 2000 Sigma, St. Louis, USA
CRABP-1 Mouse monoclonal 1: 1000 Abcam, Cambridge, England
CRABP-2 Rabbit polyclonal 1: 100 Abcam, Cambridge, England
FABP-5 Rabbit polyclonal 1: 400 Abcam, Cambridge, England
RAR-α Goat polyclonal 1: 160 Abcam, Cambridge, England
RAR-β Rabbit polyclonal 1: 50 Abcam, Cambridge, England
RAR-γ Rabbit polyclonal 1: 100 Bioss, Woburn, USA
RXR-α Rabbit polyclonal 1: 250 Abcam, Cambridge, England
RXR-β Mouse monoclonal 1: 100 Abcam, Cambridge, England
RXR-γ Rabbit polyclonal 1: 100 Abcam, Cambridge, England
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Figure 5 showed the expression of FABP5 protein was
aberrantly expressed with moderate to strong intensity
in the SeCC cases not only in hair follicles but also in
the SeCC tumor cells (n = 10/16, 65 %), whereas the
FABP5 protein in control cases was only focus in hair
follicles.
The expression of retinoic acid receptors (RAR-α, −β, −γ)
and retinoic X receptors (RXR-α, −β, −γ) were shown in
Figs. 6 & 7, respectively. Figure 6a-c showed the expression
of RAR-α receptor was mildly increased in SeCC
cases (n = 15/16, 93.75 %). However, the expression
of RAR-α was weakly positive in both SeCC and
control cases without significant differences. Aberrant
expression of RAR-β was observed in the SeCC cases
on the tumor cells (n = 13/16, 81.25 %; Fig. 6e-g),
whereas the expression of RAR-γ was weak-to-no in
SeCC cases (n = 14/16, 87.5 %; Fig. 6i-k). Therefore,
the expression of RAR-α and RAR-γ was similarly
weakly positive with no significant difference in either
group (Fig. 6a-c; i-k). The expression of RAR-β was sig-
nificantly upregulated in the SeCC group (Fig. 6e-g). Fig. 7
showed the expression of RXR-α receptor showed a nega-
tive pattern in 87.5 % of SeCC cases (n = 14/16), which
was similar to normal tissue without significant differ-
ences (Fig. 7a-c). The expression of RXR-β was increased
obviously, with mild to moderate intensity in SeCC cases
as shown in Fig. 7d, e (n = 13/16, 81.3 %). The RXR-γ ex-
pression presented with mild to moderate intensity in
SeCC cases (n = 6/16, 93.75 %; Fig. 7g, h). In summary,
the expression of RAR-β and RXR-β, −γ receptors were
significantly upregulated during the development of seba-
ceous cell carcinoma cases.
Discussion
In this study, we present the immunohistochemical ex-
pression of β-catenin, RA signaling molecules (CRABP1,
Fig. 2 Immunohistochemistry shows the expression of β-catenin in sebaceous cell carcinoma. Aberrant expression of β-catenin in SeCC cases. No
nuclear staining of β-catenin was observed in any of these SeCC cases. (a,b) case 6; (c) case 12; (d,e) case 8; (f,g) case 16; (h) case 15; (i) control case:
HF (hair follicles); SG (sebaceous gland cells). Scale bars represent 50 μm
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CRABP2, FABP5), and related retinoic acid receptors
(RARs and RXRs) in SeCC cases. Multiple predisposing
factors have been proposed, such as radiation exposure,
advanced age, race, and genetic predisposition [3–5].
However, the exact pathoetiology of SeCC remains un-
known. As there are no available specific markers for
predicting prognosis, the course of SeCC is difficult to
predict. Collins and Watt proposed that dynamic pat-
terns of CRABP expression reflect cross talk of RA and
Wnt/β-catenin signaling in different developmental and
homeostatic situations of skin [11]. Zhang, Liu and co-
workers proposed that conditional expression of a mur-
ine Ctnnb1 gene gain-of-function mutation alone caused
corneal neoplasia and neovascularization, resembling hu-
man ocular surface squamous neoplasia (OSSN) [20]. In
particular, human OSSN patients exhibited nuclear trans-
location of β-catenin. These results indicated that β-catenin
activation might have an important role in tumorigenesis,
resulting in oncogenic transformation. Sen and colleagues
showed that cytoplasmic overexpression of β-catenin found
in the majority of cases of SeCC (66 %) of eyelid which was
significantly related to tumor size [21]. Therefore, they
proposed that β-catenin overexpression in SeCC may be
due to dysregulation of the Wnt/β-catenin pathway [21].
However, its role in the pathoetiology and prognosis of se-
baceous cell carcinoma was essential to be explored further.
In this study, we also observed a significant increase in the
level of β-catenin protein in SeCC cases (n = 13/16, 81 %).
These results indicated that the oncogenic potential of the
Wnt/β-catenin transduction pathway was related to the de-
velopment of SeCC. However, specific β-catenin labeling
was not observed in the nuclei of SeCC cells. It suggests
that the mechanism of SeCC tumorigenesis was much dif-
ferent from that of human OSSN.
In addition to overexpression of β-catenin in our SeCC
cases, we also demonstrated the expression of CRABPs
and related RA receptors in SeCC cases. CRABPs binded
all-trans-RA intracellularly and might be involved in the
transfer process of RA into the cell nucleus. CRABP1
played a role in presenting RA to metabolizing (CYP26)
enzymes, and CRABP2 played a role in transfer of RA to
nuclear RARs by direct protein–protein interactions. In
our data, the CRABP1 protein was not expressed strongly
in the tumor cells of SeCC cases, whereas the CRABP2
protein was overexpressed in the tumor cells of SeCC
cases. These results indicated that CRABP2 protein might
play an important role in the pathoetiology of sebaceous
cell carcinoma.
The FABPs belonged to a group of intracellular lipid
chaperones that bind fatty acids, retinoids, and hydropho-
bic compounds, and mediate their biological functions
[22]. In particular, FABP5 was the only one of the family to
bind retinoic acid [12]. Therefore, CRABP1, CRABP2, and
FABP5 were retinoid-binding proteins expressed in mam-
malian skin and appendages that were known to regulate
RA signaling [11, 23]. In our data, the FABP5 protein was
also aberrant expressed in some tumor cells of SeCC cases.
Collins and Watt reported that CRABP1, CRABP2, and
Fig. 3 Immunohistochemistry shows varying expression of CRABP1 in sebaceous cell carcinoma. (a,b) case 16; (c) case 10; (d) case 6; (e) case14; (f) control:
E (epithelium), HF (hair follicle). Scale bars represent 50 μm
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FABP5 proteins were dynamically expressed during skin
development and in adult tissue [11]. Their findings dem-
onstrated that there was dynamic regulation of RA signal-
ing in different regions of the skin, and provided evidence
for interactions between the RA, β-catenin, and Notch
pathways [11]. Furthermore, they found that the CRABP1,
CRABP2, and FABP5 proteins were overexpressed in both
benign papillomas and malignant squamous cell carcin-
omas (SCCs) [11]. In particular, CRABP1 was expressed in
the tumor stroma, and CRABP2 and FABP5 were
expressed in the sebaceous gland cells, interfollicular
epidermis, and hair follicles. Our results supported
those molecules were also upregulated in the tumor
cells of sebaceous cell carcinoma. In this study, we
observed a significant increase in the level of expres-
sion of CRABP2 and FABP5 in SeCC cases com-
pared with controls. CRABP2 and FABP5 were
expressed in hair follicles of eyelid skin in both groups,
whereas CRABP2 and FABP5 were aberrantly expressed
in the SeCC tumor cells. In addition, we found CRABP2
and FABP5 were aberrantly expressed in severe SeCC
patients and these results may be related to distant metas-
tasis and poor prognosis (Case 16, Fig. 1d).
In 10 cases of sebaceous cell carcinoma, Chakravarti
and co-workers found that three cases had decreased
RAR-α expression (absent in three cases); six cases had
increased RAR-β expression; expression was absent in
four cases, and two cases had decreased RAR-γ expres-
sion compared with controls [24]. Moreover, RXR-α ex-
pression was decreased, RXR-β expression was low in
seven tumors, and RXR-γ expression was absent in
six tumors. They concluded that aberrant expression
of retinoid receptors in sebaceous cell carcinoma of
the eyelid might play a role in the pathogenesis and
progression of this carcinoma [24]. In our study,
RAR-β, RXR-β, and RXR-γ were predominantly
expressed in SeCC cases, whereas RAR-α, RAR-γ,
RXR-α were presented at lower levels in SeCC cases
Fig. 4 Immunohistochemistry shows the overexpression of CRABP2 in sebaceous cell carcinoma. (a,b) case 6; (c) case 7; (d,e) case 2; (f) case 11;
(g) case 16; (h, i) control: CRAMP2 is expressed in the differentiated sebaceous gland cells (SG), and hair follicles (HF). Scale bars represent 50 μm
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with no significant difference as compared with
control cases. Further studies were needed to inves-
tigate the association of dysregulation of retinoic
acid receptors and the prognosis of sebaceous cell
carcinoma.
Conclusions
Our study results indicate that the β-catenin, RA signaling
binding proteins and related RA receptors are related to
the development of sebaceous cell carcinoma. These
results reveal that the retinoic acid binding proteins
Fig. 6 Immunohistochemistry shows the expression of retinoic acid receptors (RAR-α, −β, −γ) in SeCC cases. a–d: The expression of RAR-α was
weakly positive in both groups. (a) case 2; (b) case 6; (c) case16; (d) control. e–h: Aberrant expression of RAR-β was observed in the SeCC cases
on the tumor cells. (e, f) case 6; (g) case 7; (h) control; i-l: The expression of RAR-γ was weak-to-no staining in both groups. (i) case 3; (j) case 10;
(k) case 15; (l) control . Scale bars represent 50 μm
Fig. 5 Immunohistochemistry shows the expression of FABP5 in sebaceous cell carcinoma. Aberrant expression of FABP5 in SeCC cases was
shown not only in dermal papillae (DP) but also in the SeCC tumor cells, whereas in control cases the expression was seen only in dermal
papillae (DP) and the hair follicles (HF). (a,b,c) case 2; (d) case 12; (e,f) case 9; (g,h) control. Scale bars represent 50 μm
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and related RA receptors may affect the growth of
sebaceous cell carcinoma. Our findings indicate that
retinoic acid signaling is related to the pathogenesis
of sebaceous cell carcinoma of the eyelids. Further
experiments are ongoing to study the treatment of
sebaceous cell carcinoma with retinoic acid-related
products.
Consent
Written informed consent was obtained from the pa-
tients for publication and any accompanying images. A
copy of the written consent is available for review by the
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control. g–i: The expression of RXR-γ was observed in the SeCC cases. (g) Case 14; (h) Case 11; (i) control; (i’) control. Scale bars represent 50 μm
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